Arcadia Biosciences Announces First-Quarter 2020 Financial Results and Business Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St futures muted; Mideast talks, US-China summit in focus
- Activist Jana Partners calls for Six Flags sale - WSJ
- Oil holds near two-week lows while diesel cracks hit record peak
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
Arcadia Biosciences (RKDA) Tops Q1 EPS by 83c, Revenues Miss; Reiterates FY20 Revenue Guidance Above Consensus
May 13, 2020 4:16 PM EDTArcadia Biosciences (NASDAQ: RKDA) reported Q1 EPS of $0.29, $0.83 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $309 thousand versus the consensus estimate of $800 thousand.
"This is an extraordinary moment in time for all of us," said Matt Plavan, Arcadia's president and chief executive officer. "Our priorities throughout this challenging time remain the same: to maintain the health and safety of... More
